Clarity Medical Group Holding Beheer

Beheer criteriumcontroles 1/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Chris Hui

Algemeen directeur

HK$4.5m

Totale compensatie

Percentage CEO-salaris	66.8%
Dienstverband CEO	less than a year
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	2.4yrs
Gemiddelde ambtstermijn bestuur	2.4yrs

Recente managementupdates

Recent updates

Here's Why We're Watching Clarity Medical Group Holding's (HKG:1406) Cash Burn Situation

Aug 14

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Mar 21

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Dec 26

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Aug 16

Analyse CEO-vergoeding

Hoe is Chris Hui's beloning veranderd ten opzichte van Clarity Medical Group Holding's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Mar 31 2024	HK$4m	HK$3m	-HK$76m
Dec 31 2023	n/a	n/a	-HK$53m
Sep 30 2023	n/a	n/a	-HK$31m
Jun 30 2023	n/a	n/a	-HK$17m
Mar 31 2023	HK$2m	HK$2m	-HK$3m
Dec 31 2022	n/a	n/a	HK$4m
Sep 30 2022	n/a	n/a	HK$11m
Jun 30 2022	n/a	n/a	HK$12m
Mar 31 2022	HK$27k	n/a	HK$13m

Compensatie versus markt: Chris's total compensation ($USD577.29K) is above average for companies of similar size in the Hong Kong market ($USD235.07K).

Compensatie versus inkomsten: Chris's compensation has increased whilst the company is unprofitable.

CEO

Chris Hui (56 yo)

less than a year

Tenure

HK$4,490,000

Compensatie

Mr. Yung Hui, also known as Chris, is Co-Chief Executive Officer of Clarity Medical Group Holding Limited from September 9, 2024 and is its Executive Director from June 30, 2022. He served as External Supe...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Yung Hui	Co-CEO & Executive Director	less than a year	HK$4.49m	geen gegevens
Tsz Hong Lo	Executive Director	5.7yrs	HK$738.00k	0.36% HK$ 754.1k
Wai Ip Tse	Executive Director	2.4yrs	HK$406.00k	14.8% HK$ 31.3m
Bo Jiang	CEO & Executive Director	less than a year	geen gegevens	geen gegevens
Kin Ho	Financial Controller	9.7yrs	geen gegevens	geen gegevens
Po Yu Chan	Company Secretary	no data	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren management: 1406's management team is considered experienced (2.4 years average tenure).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Yung Hui	Co-CEO & Executive Director	2.4yrs	HK$4.49m	geen gegevens
Tsz Hong Lo	Executive Director	5.7yrs	HK$738.00k	0.36% HK$ 754.1k
Wai Ip Tse	Executive Director	2.4yrs	HK$406.00k	14.8% HK$ 31.3m
Bo Jiang	CEO & Executive Director	less than a year	geen gegevens	geen gegevens
Ting Yuk Wu	Non-Executive Chairman	5.7yrs	HK$480.00k	0.71% HK$ 1.5m
Can Wang	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens
Wei Zhao	Non-Executive Director	5.7yrs	HK$160.00k	geen gegevens
Hankin Li	Independent Non-Executive Director	5.7yrs	HK$240.00k	geen gegevens
Jessica Cheng	Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

2.4yrs

Gemiddelde duur

46yo

Gemiddelde leeftijd

Ervaren bestuur: 1406's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Clarity Medical Group Holding Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Clarity Medical Group Holding Limited Announces CEO Changes

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Recent updates

Clarity Medical Group Holding Limited Announces CEO Changes

Here's Why We're Watching Clarity Medical Group Holding's (HKG:1406) Cash Burn Situation

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Full year 2024 earnings released: HK$0.14 loss per share (vs HK$0.006 loss in FY 2023)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 30, 2024

Clarity Medical Group Holding Limited Appoints Cheng Jessica as Independent Non-Executive Director and Audit Committee

Executive Director recently sold HK$5.6m worth of stock

Executive Director recently sold HK$157k worth of stock

Clarity Medical Group Holding Limited Announce Demise of Lau Wan Yee Joseph, Independent Non-Executive Director

Executive Director recently sold HK$482k worth of stock

Executive Director recently sold HK$2.0m worth of stock

Executive Director recently sold HK$2.0m worth of stock

First half 2024 earnings released: HK$0.038 loss per share (vs HK$0.015 profit in 1H 2023)

New major risk - Revenue size

New minor risk - Share price stability

Clarity Medical Group Holding Limited to Report First Half, 2024 Results on Nov 28, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Six Months Ended 30 September 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

Clarity Medical Group Holding Limited, Annual General Meeting, Sep 20, 2023

Full year 2023 earnings released: HK$0.006 loss per share (vs HK$0.035 profit in FY 2022)

New minor risk - Financial data availability

Clarity Medical Group Holding Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

Clarity Medical Group Holding Limited Provides Earnings Guidance for the Year Ended 31 March 2023

Executive Director recently bought HK$589k worth of stock

Investor sentiment improves as stock rises 16%

Investors Could Be Concerned With Clarity Medical Group Holding's (HKG:1406) Returns On Capital

Non-Executive Director exercised options to buy HK$4.5m worth of stock.

Weak Statutory Earnings May Not Tell The Whole Story For Clarity Medical Group Holding (HKG:1406)

Now 24% undervalued after recent price drop

Less than half of directors are independent

Clarity Medical Group Holding Limited to Report First Half, 2023 Results on Nov 28, 2022

Clarity Medical Group Holding Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 September 2022

Investor sentiment improved over the past week

Executive Director recently bought HK$110k worth of stock

Investor sentiment deteriorated over the past week

Executive Director recently bought HK$59k worth of stock

Executive Director recently bought HK$735k worth of stock

Clarity Medical Group Holding Limited's (HKG:1406) Shares Climb 28% But Its Business Is Yet to Catch Up

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Executive Director recently bought HK$166k worth of stock

Clarity Medical Group Holding Limited Announces Executive Changes

Full year 2022 earnings released: EPS: HK$0.035 (vs HK$0.095 in FY 2021)

Clarity Medical Group Holding Limited, Annual General Meeting, Aug 26, 2022

Clarity Medical Group Holding Limited to Report Fiscal Year 2022 Results on Jun 28, 2022

Clarity Medical Group Holding Limited Provides Consolidated Guidance for the Year Ended March 31, 2022

Executive Director recently sold HK$1.3m worth of stock

Less than half of directors are independent

Executive Director recently sold HK$378k worth of stock

Investor sentiment improved over the past week

Executive Director recently sold HK$58k worth of stock

Investor sentiment deteriorated over the past week

Insider recently bought HK$7.6m worth of stock

Clarity Medical Group Holding Limited has completed an IPO in the amount of HKD 217.6 million.

Less than half of directors are independent

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd